Crestal Bone Changes Following Equi-crestal Versus Subcrestal Implant Placement
Radiographic Evaluation of Crestal Bone Changes Following Equi-crestal Versus Subcrestal Implant Placement in Mandibular Posterior Augmented Ridge. A Randomized Controlled Clinical Trial.
1 other identifier
interventional
28
1 country
1
Brief Summary
Statement of problem: The stability of peri-implant bone is a crucial factor for the long-term success of dental implants, where crestal bone plays a significant role in both the primary as well as the long- term implant stability. A bone loss of 1.5 mm during the first year of loading has been acceptable according to the early standards. However, more bone stability can be expected with the development in implant designs and surfaces over the past decades. Aim of the study: the aim of this study is to radiographically assess the crestal bone changes following delayed implant placement in mandibular previously augmented posterior sites, comparing cases with equicrestal implant placement with subcrestal implant placement
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 3, 2025
CompletedFirst Posted
Study publicly available on registry
January 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 27, 2026
January 1, 2025
1.5 years
January 3, 2025
January 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Crestal bone changes
Periapical digital radiographs to determine the amount of crestal bone lose in mm
at baseline,3, 6 ,12 and 18 months
Secondary Outcomes (2)
Keratinized tissue width
at baseline, 3,6,12 and 18 months
Patient satisfaction
at baseline, 6 ,12 and 18 months
Study Arms (2)
Subcrestal implant placement
ACTIVE COMPARATORDelayed implant placement 2 mm subcrestally in missing mandibular posterior site.
Crestal implant placement
ACTIVE COMPARATORDelayed implant placement equicrestally in missing mandibular posterior site.
Interventions
Delayed implant placement equicrestally in missing mandibular posterior site.
Delayed implant placement 2 mm subcrestally in missing mandibular posterior site.
Eligibility Criteria
You may qualify if:
- Patients older than 21 years.
- Patients having augmented (by 50/50 particulate xenograft and autogenous bone) edentulous posterior site with vertical bone height of \> 10 mm in the mandible with a width of ridge ≥ 7 mm
- Adequate Inter-arch space for implant placement
- Favorable occlusion (no traumatic occlusion).
- Good oral hygiene.•Accepts 18 months follow-up period (cooperative patient)
- The patient provides informed consent.
You may not qualify if:
- Patients with inadequate bone volume and/ or quality
- Patients with remaining roots or with signs of acute infection related to the area of interest.
- Patients having systemic conditions that interfere with normal wound healing
- Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits .
- Smoker patients.
- Pregnant women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Misr International University
Cairo, Egypt
Study Officials
- STUDY CHAIR
hani el nahas professor, Professor
Misr International University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants will not know whether the implant is placed crestal or subcrestal Outcome assessor (primary and secondary outcomes) \& biostatistician will be blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 3, 2025
First Posted
January 6, 2025
Study Start
January 1, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 27, 2026
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share